PERROTTA, Silverio
 Distribuzione geografica
Continente #
NA - Nord America 5.889
EU - Europa 5.321
AS - Asia 958
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 10
OC - Oceania 4
Totale 12.208
Nazione #
US - Stati Uniti d'America 5.840
IE - Irlanda 1.662
IT - Italia 831
UA - Ucraina 721
GB - Regno Unito 666
DE - Germania 511
CN - Cina 379
SG - Singapore 375
SE - Svezia 252
FR - Francia 221
FI - Finlandia 200
GR - Grecia 134
TR - Turchia 93
BE - Belgio 46
CA - Canada 42
KR - Corea 23
PK - Pakistan 20
CH - Svizzera 13
IN - India 13
SA - Arabia Saudita 13
CZ - Repubblica Ceca 12
EU - Europa 10
HK - Hong Kong 8
NL - Olanda 8
BR - Brasile 7
ES - Italia 7
PL - Polonia 7
EG - Egitto 6
ET - Etiopia 6
VN - Vietnam 6
MX - Messico 5
BG - Bulgaria 4
DK - Danimarca 4
HU - Ungheria 4
ID - Indonesia 4
JP - Giappone 4
DZ - Algeria 3
IR - Iran 3
MK - Macedonia 3
MY - Malesia 3
RO - Romania 3
AT - Austria 2
AU - Australia 2
GE - Georgia 2
IL - Israele 2
IS - Islanda 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
RS - Serbia 2
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
IM - Isola di Man 1
IQ - Iraq 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RU - Federazione Russa 1
SC - Seychelles 1
TW - Taiwan 1
Totale 12.208
Città #
Dublin 1.652
Jacksonville 1.133
Chandler 902
Chicago 467
Santa Clara 275
Singapore 251
Princeton 249
Wilmington 237
Caserta 219
Medford 210
Boardman 189
Ann Arbor 184
Bremen 168
Falls Church 144
San Mateo 137
Roxbury 127
Woodbridge 126
Beijing 122
New York 103
Ashburn 69
Nanjing 67
Naples 57
Cambridge 56
Des Moines 54
Napoli 46
Brussels 34
Redwood City 30
Munich 29
Elora 28
Grumo Nevano 28
Düsseldorf 27
Mountain View 27
Jinan 26
Seoul 23
Norwalk 22
Helsinki 21
Rome 21
Kunming 20
Milan 19
Nanchang 19
Istanbul 18
Houston 17
Auburn Hills 13
London 12
Pozzuoli 12
Shenyang 12
Brno 11
Nocera Inferiore 11
Riyadh 11
Kontich 10
Fairfield 9
San Sebastiano al Vesuvio 9
Tianjin 9
Ningbo 8
Zhengzhou 8
Aversa 7
Dearborn 7
Florence 7
Haikou 7
Lappeenranta 7
Los Angeles 7
Oxford 7
Poggiomarino 7
Dong Ket 6
Guangzhou 6
Hangzhou 6
Hebei 6
Hefei 6
Lanzhou 6
Parma 6
Scafati 6
Eboli 5
Hong Kong 5
Islamabad 5
Marcianise 5
Portici 5
Salerno 5
Shanghai 5
Stella Cilento 5
Bologna 4
Casoria 4
Centrale 4
Cutrofiano 4
Guadalajara 4
Lahore 4
Madrid 4
Marano Di Napoli 4
Ottawa 4
Padova 4
Pagani 4
Palma Campania 4
Seattle 4
Taizhou 4
Verona 4
Amsterdam 3
Ariano Irpino 3
Central 3
Changchun 3
Changsha 3
Città Sant'Angelo 3
Totale 8.010
Nome #
Osteoporosis in thalassemia major: A possible role of chelation therapy. 765
The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells. 114
The Italian survey on hereditary spherocytosis 110
Tyrosine kinase inhibitors and mesenchymal stromal cells: effects on self-renewal, commitment and functions 95
HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. 88
Endocannabinoid Research Group (ERG), Italy. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. 88
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 87
Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology. 83
Iron overload enhances human mesenchymal stromal cell growth and hampers matrix calcification 81
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 80
Erythrocyte genotyping for transfusion-dependent patients at the Azienda Universitaria Policlinico of Naples 79
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation) 76
Very early onset of autoimmune thyroiditis in a toddler with severe hypothyroidism presentation: A case report 76
Cytoskeletal behaviour in spectrin and in band 3 deficient spherocytic red cells: Evidence for a differentiated splenic conditioning role 75
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 74
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 74
A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemia 74
Clinical and Genetic Findings in Children with Neurofibromatosis Type 1, Legius Syndrome, and Other Related Neurocutaneous Disorders 73
LEOPARD syndrome: clinical dilemmas in differential diagnosis of RASopathies. 72
Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. 72
Early-onset central diabetes insipidus is associated with de novo arginine vasopressin-neurophysin II or Wolfram syndrome 1 gene mutations 71
p27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases. 71
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura. 70
ERITROCITOSI CONGENITA CAUSATA DA ALTERAZIONI DEL SISTEMA SENSORE DELL’OSSIGENO 69
Childhood Head and Neck Lymphadenopathy: A Report by a Single Institution (2003-2017) 69
Targeted molecular therapy (modified RIST regimen) in relapsed high risk stage IV neuroblastoma: two cases report 68
Hereditary spherocytosis (HS) due to loss of anion exchange transporter 66
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin 65
The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function 65
A cancer-associated CDKN1B mutation induces p27 phosphorylation on a novel residue: a new mechanism for tumor suppressor loss-of-function 65
The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy 64
Von Hippel-Lindau-dependent polycythemia is endemic on the island of Ischia: identification of a novel cluster. 64
Vitamin A and infancy. Biochemical, functional, and clinical aspects 64
Vitamin A and infancy. Biochemical, functional, and clinical aspects 63
Apparently normal ankyrin content in unsplenectomized hereditary spherocytosis patients with the inactivation of one ankyrin (ANK1) allele 63
Alpha I/65 hereditary elliptocytosis in southern Italy: evidence for an African origin 63
Arg(1809) substitution in neurofibromin: further evidence of a genotype-phenotype correlation in neurofibromatosis type 1 63
National systematic approach to the management of asplenia: the set up of the Italian Network on Asplenia 63
Frequent de novo monoallelic expression of beta-spectrin gene (SPTB) in children with hereditary spherocytosis and isolated spectrin deficiency 62
Iron overload causes osteoporosis in Thalassemia Major patients through interaction with TRPV1 channels. 62
Erythropoietin receptors on cancer cells: a still open question. 62
Infant hypervitaminosis A causes severe anemia and thrombocytopenia: evidence of a retinol-dependent bone marrow cell growth inhibition 61
Ankyrin Napoli: a de novo deletional frameshift mutation in exon 16 of ankyrin gene (ANK1) associated with spherocytosis 61
Resveratrol mimics insulin activity in the adipogenic commitment of human bone marrow mesenchymal stromal cells. 61
A deletional frameshift mutation in spectrin beta-gene associated with hereditary elliptocytosis in spectrin Napoli 61
Tumori renali: esperienza trentennale monoistituzionale 61
Concordanza tra visita oculistica e RM encefalo nello screening del glioma delle vie ottiche nei pazienti pediatrici con neurofibromatosi tipo 1 61
Studio retrospettivo sulle complicanze emato-oncologiche nella neurofibromatosi tipo 1 in età pediatrica 61
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 60
Erythrocyte membrane protein alterations underlying clinical heterogeneity in hereditary spherocytosis 60
Increased Membrane‐Protein Methylation in Hereditary Spherocytosis: A Marker of Cytoskeletal Disarray 60
Abnormalities of erythrocyte glycoconjugates are identical in two families with congenital dyserythropoietic anemia type II with different chromosomal localizations of the disease gene 60
Congenital Dyserythropoietic Anemia Type II: molecular analysis and expression of the SEC23B Gene. 60
Identificazione di una mutazione del gene PAX2 in una famiglia con RVU isolato 60
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. 59
Unusual association of non-anaplastic Wilms tumor and Cornelia de Lange syndrome: Case report 59
Seizures in children with neurofibromatosis type 1: Is neurofibromatosis type 1 enough? 59
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 59
Neuropsychiatric Manifestations, Reduced Self-Esteem and Poor Quality of Life in Children and Adolescents with Neurofibromatosis Type 1 (NF1): The Impact of Symptom Visibility and Bullying Behavior 58
A genome search for primary vesicoureteral reflux shows further evidence for genetic heterogeneity 57
Frequent de novo mutations of the ANK1 gene mimic a recessive mode of transmission in hereditary spherocytosis: three new ANK1 variants: ankyrins Bari, Napoli II and Anzio 57
Genetic basis of congenital erythrocytosis: mutation update and online databases. 57
Cardiac autonomic regulation in response to a mixed meal is impaired in obese children and adolescents: the role played by insulin resistance. 57
{beta}-spectrinBari: a truncated {beta}-chain responsible for dominant hereditary spherocytosis. 57
Time trends of cancer incidence in childhood in Campania region: 25 years of observation 57
Multiple spinal nerve enlargement and SOS1 mutation: further evidence of overlap between Neurofibromatosis type 1 and Noonan phenotype 57
Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1 57
Abbreviated breast magnetic resonance imaging (FAST-MRI): A novel approach to breast cancer screening in patients with previous Hodgkin lymphoma 57
Analysis of N-ras gene mutations in medulloblastomas by polymerase chain reaction and oligonucleotide probes in formalin-fixed, paraffin-embedded tissues 56
Glucose 6-phosphate dehydrogenase deficiency and red cell membrane defects: additive or synergistic interaction in producing chronic haemolytic anaemia 56
Blood transfusions and adverse acute events: a retrospective study from 214 transfusion-dependent pediatric patients comparing transfused blood components by apheresis or by whole blood 56
A rapid method for the detection of alpha I/65 hereditary elliptocytosis 55
Type III Bartter-like syndrome in an infant boy with Gitelman syndrome and autosomal dominant familial neurohypophyseal diabetes insipidus. 54
Prevalence and risk factors for pulmonary arterial hypertension in a large group of β-thalassemia patients using right heart catheterization: a Webthal study. 54
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment 54
Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience 54
L1 effects on reactive oxygen (ROS) and nitrogen species (RNS) release, hemoglobin oxidation, low molecular weight antioxidants, and antioxidant enzyme activities in red and white blood cells of thalassemic patients 53
Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study 53
Mild elliptocytosis associated with the alpha 34 Arg-->Trp mutation in spectrin Genova (alpha I/74) 53
4.2 Nippon mutation in a non-Japanese patient with hereditary spherocytosis [3] 53
Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. 52
COINHERITANCE OF GILBERT SYNDROME INCREASES THE RISK FOR DEVELOPING GALLSTONES IN PATIENTS WITH HEREDITARY SPHEROCYTOSIS 52
Evaluation of leptin protein levels in patients with Cooley's anaemia 52
Deferasirox: la chelazione ottimale nelle anemie trasfusione-dipendenti 52
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 52
Auditory cortex hypoperfusion: a metabolic hallmark in Beta Thalassemia 52
ROBO2 gene variants are associated with familial vesicoureteral reflux 51
Membrane association of peroxiredoxin-2 in red cells is mediated by n-terminal cytoplasmic domain of band 3. 51
Characterization of red cell membrane proteins as a function of red cell density: Annexin VII in different forms of hereditary spherocytosis 51
Genomewide search for dehydrated hereditary stomatocytosis (hereditary xerocytosis): mapping of locus to chromosome 16 (16q23-qter) 51
Frequency of congenital dyserythropoietic anemias in Europe 51
Splenectomy for hereditary spherocytosis: complete, partial or not at all? 51
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 51
A novel MEIS2 mutation explains the complex phenotype in a boy with a typical NF1 microdeletion syndrome 51
Hereditary spherocytosis characterized by increased spectrin/band 3 ratio 50
Non-allelic heterogeneity in familial unilateral renal adysplasia 50
Organizing national responses for rare blood disorders: The Italian experience with sickle cell disease in childhood 50
Treatment with short-term, high-dose cyclosporin A in children with refractory chronic idiopathic thrombocytopenic purpura 50
Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects 50
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study 50
Totale 6.973
Categoria #
all - tutte 56.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.332


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020919 0 0 0 0 207 44 271 70 168 39 84 36
2020/20211.772 175 19 185 131 284 31 257 189 26 231 183 61
2021/20221.995 175 58 63 86 543 34 105 69 78 140 179 465
2022/20233.880 389 152 336 302 378 295 12 192 1.612 35 100 77
2023/20241.272 105 40 69 137 426 120 22 56 24 11 87 175
2024/2025643 28 41 43 124 407 0 0 0 0 0 0 0
Totale 12.751